Waltham, MA, United States of America

Krishna Patel

This inventor holds 1 USPTO granted patent. Top assignee: Symbiotic Capital Agency LLC, as Administrative and Collateral Agent. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishna Patel. Retrieved from https://idiyas.com/inventor/krishna-patel-x72jzcwc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Krishna Patel

Introduction

Krishna Patel is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of biochemistry, particularly with his work on glycosyltransferase enzymes. His innovative approach has led to the development of a unique patent that showcases his expertise and creativity.

Latest Patents

Krishna Patel holds a patent for the invention titled "Uridine Diphosphate-Dependent Glycosyltransferase Enzyme." This patent represents a significant advancement in the understanding and application of glycosyltransferase enzymes, which play a crucial role in various biological processes.

Career Highlights

Currently, Krishna Patel works at Symbiotic Capital Agency LLC as an Administrative and Collateral Agent. His role involves managing administrative tasks and overseeing collateral agreements, which are essential for the smooth operation of the company. His background in biochemistry complements his responsibilities, allowing him to contribute effectively to the organization.

Collaborations

Throughout his career, Krishna has collaborated with talented individuals such as Jason Donald and Swati Gupta. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Krishna Patel is a notable inventor whose work in biochemistry has led to valuable patents and contributions to his field. His role at Symbiotic Capital Agency LLC further highlights his commitment to innovation and excellence.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…